Bestinvest Logo
Why us
Planning ahead
Insights
fund

T. Rowe Price US Smaller Companies Equity Q GBP

Bestinvest LogoA well diversified portfolio of small US companies

PRICE (INC)

3997p

PRICE (ACC)

3997p

INITIAL CHARGE

0%

ANNUAL MANAGEMENT CHARGE

0.95%

ONGOING CHARGE

1.11%

YIELD

0%

1 YEAR
-0.70%

Prices as at 01 Jul 2022.

We don’t currently provide commentary on this fund.

Past performance is not an indication of future performance.

Capital at risk.

This fund aims to increase the value of its shares, over the long term, through growth in the value of its investments. The fund invests mainly in a widely diversified portfolio of smaller capitalisation companies(up to $9bn market cap) listed in the United States. The portfolio is diversified across more than 200 holdings and is a blend of both value and growth styles.

Fund summary

SectorNorth American Smaller Cos
StructureOFFSHORE FUND
LaunchedJanuary 2013
Size£2,201m
Yield0%
Charging BasisIncome
Dividends paidAcc units only

Charges

Standard Initial Charge0%
Initial Charge Via BestInvest0%
Additional Bid/Offer Spread0%
Annual Management Charge0.95%
Ongoing Charges Figure1.11%

Investment Process

T Rowe Price is Baltimore based and has a team of 140 equity analysts, 40 of whom are focused on smaller companies. The team meets more than 1,000 companies each year. Smaller companies are much less well covered by other stock market professionals which means having a large, experienced in-house team of analysts is a distinct advantage. Companies must have market values between $100m to $9bn which gives them a pool of 2,500 stocks from which to build a portfolio of around 200 holdings. Sector weights are set by bottom–up stock selection though with an eye on keeping a broad sector diversification to limit risk/volatility. Both growth and value stocks are chosen. Position size is set by their confidence in the investment thesis and the quality of the company's business model. The risks of investing in small companies are somewhat offset by holding several companies in any given sector - for example in biotechnology where each company is reliant on the success (or otherwise) of a single drug, the manager will take positions in several such companies.

The information on this website is not intended to be advice or a recommendation to buy, sell or hold any investment mentioned. The value of investments and the income from them can go down as well as up and you may not get back the amount invested.

Past performance is not a guide to future performance. View full risk warning